Published in Circ Res on September 01, 1971
Lidocaine block of cardiac sodium channels. J Gen Physiol (1983) 5.13
Cat ventricular muscle treated with D600: characteristics of calcium channel block and unblock. J Physiol (1984) 1.30
Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats. J Clin Invest (2009) 1.04
Effects of stimulation and diphenylhydantoin on the intracellular sodium activity in Purkinje fibres of sheep heart. J Physiol (1985) 0.97
The mechanism of action of the optical enantiomers of verapamil against ischaemia-induced arrhythmias in the conscious rat. Br J Pharmacol (1986) 0.96
Comparative electrophysiological effects of Org 6001, a new orally active antidysrhythmic agent, and lignocaine on human ventricular muscle. Br J Pharmacol (1980) 0.92
Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle. Br J Pharmacol (1979) 0.90
Sodium channels from human brain RNA expressed in Xenopus oocytes. Basic electrophysiologic characteristics and their modification by diphenylhydantoin. J Clin Invest (1989) 0.82
Electrophysiological effects of the salicylates on isolated atrial muscle of the rabbit. Br J Pharmacol (1982) 0.82
The effects on cardiac muscle and nerve of a fluorinated decahydroquinoline derivative, L7810, rapidly absorbed after oral administration. Br J Pharmacol (1973) 0.82
Investigations of the mode of action of a new antidysrhythmic drug, Kö 1173. Br J Pharmacol (1972) 0.81
The effect of prolonged treatment with oxyfedrine on intracellular potentials and on other features of cardiac function in rabbits and guinea-pigs. Br J Pharmacol (1973) 0.78
Pharmacological analysis of established ventricular fibrillation. Br J Pharmacol (1990) 0.77
Insulin Facilitates the Recovery of Myocardial Contractility and Conduction during Cardiac Compression in Rabbits with Bupivacaine-Induced Cardiovascular Collapse. Anesthesiol Res Pract (2012) 0.75
[Diphenylhydantoin: a comparative study on normal cats and animals intoxicated with digitalis glycosides. Electrophysiological, hemodynamic, and electrocardiographic studies (author's transl)]. Basic Res Cardiol (1974) 0.75
[Potassium-dependent modification of the lidocaine effect: an experimental investigation (author's transl)]. Basic Res Cardiol (1976) 0.75
The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol (1970) 5.24
Contribution of isolated general practitioner maternity units. Br Med J (Clin Res Ed) (1984) 4.36
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med (1995) 3.56
Antifibrillatory action. J Physiol (1962) 3.36
Death certification by house officers and general practitioners--practice and performance. J Public Health Med (1993) 2.97
"Inaccuracy' in death certification--where are we now? J Public Health Med (1996) 2.82
A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol (1970) 2.78
Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med (1994) 2.68
The effect of altered thyroid state on atrial intracellular potentials. J Physiol (1970) 2.53
Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol (1995) 2.31
Skeletons of terrestrial cetaceans and the relationship of whales to artiodactyls. Nature (2001) 1.98
New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prog Cardiovasc Dis (1980) 1.95
Abscisic Acid localization and metabolism in barley aleurone layers. Plant Physiol (1979) 1.71
Reduction of enzyme levels by propranolol after acute myocardial infarction. Circulation (1978) 1.68
Plasma propranolol concentration in patients with angina and acute myocardial infarction. Clin Exp Pharmacol Physiol (1976) 1.68
Effects of intravenous verapamil on hemodynamics in patients with heart disease. Am Heart J (1977) 1.63
Effects of amiodarone on thyroid function in patients with ischaemic heart disease. Br Heart J (1975) 1.63
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation (2000) 1.63
Cytologic findings in aspirated hydatid fluid. Acta Cytol (1989) 1.58
A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function. Br J Pharmacol (1969) 1.57
Amiodarone and thyroid function. Prog Cardiovasc Dis (1989) 1.55
Review of wheat improvement for waterlogging tolerance in Australia and India: the importance of anaerobiosis and element toxicities associated with different soils. Ann Bot (2008) 1.53
Mode of action of beta receptor antagonists on cardiac muscle. Am J Cardiol (1966) 1.52
Comparative mechanisms of action of antiarrhythmic drugs. Am Heart J (1974) 1.52
AN INEXPENSIVE INTEGRATING LIGHT RECORDER. Plant Physiol (1941) 1.51
Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group. Am J Cardiol (1999) 1.49
Verapamil: a review of its pharmacological properties and therapeutic use. Drugs (1978) 1.47
Ascertaining causes of neonatal deaths using verbal autopsy: current methods and challenges. J Perinatol (2008) 1.46
The effects of prolonged beta-adrenoceptor blockade on heart weight and cardiac intracellular potentials in rabbits. Cardiovasc Res (1975) 1.44
Morphometric changes in rabbit ventricular myocardium produced by long-term beta-adrenoceptor blockade. Lancet (1977) 1.43
The unstable intertrochanteric fracture: treatment with a valgus osteotomy and I-beam nail-plate. A preliminary report of one hundred cases. J Bone Joint Surg Am (1970) 1.43
Non-Q-wave myocardial infarction-current status. J Assoc Physicians India (1988) 1.40
A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function. Cardiovasc Res (1972) 1.36
Effects of verapamil on infarct size following experimental coronary occlusion. Cardiovasc Res (1975) 1.32
Data quality in population-based cancer registration: an assessment of the Merseyside and Cheshire Cancer Registry. Br J Cancer (1997) 1.30
Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J Lab Clin Med (1978) 1.28
Therapeutic implications of slow-channel blockade in cardiocirculatory disorders. Circulation (1980) 1.26
Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone. Am Heart J (1981) 1.25
Cytopathogenic effect of Trichomonas vaginalis on human vaginal epithelial cells cultured in vitro. Infect Immun (2000) 1.25
A SIMPLIFIED INTEGRATING LIGHT RECORDER FOR FIELD USE. Plant Physiol (1943) 1.25
Noninvasive identification of a high risk subset of patients with acute inferior myocardial infarction. Am J Cardiol (1980) 1.24
Ionic mechanisms in heart muscle in relation to the genesis and the pharmacological control of cardiac arrhythmias. Pharmacol Rev (1978) 1.23
Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J Clin Endocrinol Metab (1981) 1.22
Effects of cardioselective beta adrenoceptor blockade on specific airways resistance in normal subjects and in patients with bronchial asthma. Clin Pharmacol Ther (1976) 1.22
Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations. Am Heart J (1985) 1.22
Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. J Am Coll Cardiol (1999) 1.21
Failure of ST segment elevation to predict severity of acute myocardial infarction. Br Heart J (1976) 1.21
Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone. Circulation (1999) 1.20
Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics. J Am Coll Cardiol (1986) 1.20
The frequency and prognostic significance of electrocardiographic abnormalities in clinically normal individuals. Prog Cardiovasc Dis (1981) 1.19
Studies on pathogenic and non-pathogenic small free-living amoebae and the bearing of nuclear division on the classification of the order amoebida. Philos Trans R Soc Lond B Biol Sci (1970) 1.19
The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs. Circulation (1979) 1.17
Cardiospecificity of -receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular -adrenoceptors of propranolol, of practolol and its ortho-substituted isomer, and of oxprenolol and its para-substituted isomer. Cardiovasc Res (1973) 1.17
Mechanism of rest and nocturnal angina: observations during continuous hemodynamic and electrocardiographic monitoring. Circulation (1979) 1.16
Early effects of gibberellic acid on barley aleurone layers. Biochem Biophys Res Commun (1968) 1.15
Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol (1987) 1.14
Mucosal melanoma of the head and neck. Clin Otolaryngol Allied Sci (1998) 1.14
Amiodarone: historical development and pharmacologic profile. Am Heart J (1983) 1.12
Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death. J Hypertens (1992) 1.12
Electrophysiologic effects of amiodarone: experimental and clinical observation relative to serum and tissue drug concentrations. Am Heart J (1984) 1.11
Climate and painful crisis of sickle-cell disease in Jamaica. Br Med J (1976) 1.10
Local anaesthetic and anti-arrhythmic actions of alprenolol relative to its effect on intracellular potentials and other properties of isolated cardiac muscle. Br J Pharmacol (1970) 1.10
Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med (2000) 1.09
Pacemaker selectivity: influence on rabbit atria of ionic environment and of alinidine, a possible anion antagonist. Cardiovasc Res (1981) 1.09
Asthma deaths in Mersey region 1989-1990. J Public Health Med (1995) 1.06
Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy. Circulation (1982) 1.05
Left ventricular ejection fraction determined by radionuclide ventriculography in early stages of first transmural myocardial infarction. Relation to short-term prognosis. Am J Cardiol (1980) 1.05
Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias. Drugs (1979) 1.05
Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications. J Cardiovasc Electrophysiol (1995) 1.04
Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. Am J Cardiol (1981) 1.04
New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer (1999) 1.03
Chemosensitivity of cardiac muscle. J Physiol (1967) 1.02
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias. Drugs (1974) 1.02
Amiodarone in refractory life-threatening ventricular arrhythmias. Ann Intern Med (1983) 1.02
QTLs associated with root traits increase yield in upland rice when transferred through marker-assisted selection. Theor Appl Genet (2012) 1.01
Pharmacological basis for the therapeutic applications of slow-channel blocking drugs. Angiology (1982) 1.00
Electrophysiological basis for a rational approach to antidysrhythmic drug therapy. Adv Drug Res (1974) 0.99
Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias. Circulation (1985) 0.98
Calcium antagonists. Clinical use in the treatment of arrhythmias. Drugs (1983) 0.97
When is QT prolongation antiarrhythmic and when is it proarrhythmic? Am J Cardiol (1989) 0.97
Delay in presentation of women with breast disease. Clin Oncol (1976) 0.97
Genetic study of Welsh gypsies. J Med Genet (1977) 0.97
The mechanism of action of calcium antagonists relative to their clinical applications. Br J Clin Pharmacol (1986) 0.96
Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease. Am Heart J (1985) 0.96
Urea excretion by rabbits. J Physiol (1946) 0.95
Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954. Biochem Pharmacol (2009) 0.95
Kinetoplastid membrane protein-11 (KMP-11) is differentially expressed during the life cycle of African trypanosomes and is found in a wide variety of kinetoplastid parasites. Mol Biochem Parasitol (1995) 0.95
The effects of various fatty acids on action potential shortening during sequential periods of ischaemia and reperfusion. J Mol Cell Cardiol (1980) 0.95
Changes in myocardial blood flow and S-T segment elevation following coronary artery occlusion in dogs. Circ Res (1975) 0.94
Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials. Clin Exp Pharmacol Physiol (1976) 0.94
Proceedings: Possible explanation for protective action of long-term beta-adrenoceptor blockade after myocardial infarction. Br Heart J (1976) 0.92
Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications. J Am Coll Cardiol (1984) 0.92
Effects of amiodarone and its metabolite, desethylamiodarone, on the electrophysiologic properties of isolated cardiac muscle. J Cardiovasc Pharmacol (1986) 0.92
Synthesis of a ubiquitously present new HSP60 family protein is enhanced by heat shock only in the Malpighian tubules of Drosophila. Experientia (1996) 0.92